Technical Analysis for REPL - Replimune Group, Inc.

Grade Last Price % Change Price Change
B 12.19 -2.48% -0.31
REPL closed down 2.48 percent on Tuesday, November 12, 2024, on 70 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Pocket Pivot Bullish Swing Setup -2.48%
NR7 Range Contraction -2.48%
New 52 Week High Strength -2.48%
Gapped Up Strength -2.48%
Upper Bollinger Band Touch Strength -2.48%

   Recent Intraday Alerts

Alert Time
Fell Below 10 DMA about 6 hours ago
20 DMA Support about 10 hours ago
10 DMA Support about 10 hours ago
Down 5% about 10 hours ago
Down 3% about 10 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP, RP2, and RP3. The Company is focused on Phase 1/2 clinical trial with its lead product candidate, RP1, in approximately 150 patients with a range of solid tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Immunotherapy Cancer Treatment Virotherapy Immunotherapy Products Oncolytic Virus Experimental Cancer Treatments Transgene Sa Akseli Hemminki Rp1

Is REPL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.97
52 Week Low 4.92
Average Volume 661,951
200-Day Moving Average 8.99
50-Day Moving Average 11.42
20-Day Moving Average 11.97
10-Day Moving Average 12.19
Average True Range 0.67
RSI (14) 54.55
ADX 16.82
+DI 17.04
-DI 23.52
Chandelier Exit (Long, 3 ATRs) 10.97
Chandelier Exit (Short, 3 ATRs) 11.94
Upper Bollinger Bands 12.71
Lower Bollinger Band 11.24
Percent B (%b) 0.65
BandWidth 12.28
MACD Line 0.29
MACD Signal Line 0.28
MACD Histogram 0.0092
Fundamentals Value
Market Cap 748.32 Million
Num Shares 61.4 Million
EPS -3.16
Price-to-Earnings (P/E) Ratio -3.86
Price-to-Sales 0.00
Price-to-Book 1.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.91
Resistance 3 (R3) 13.85 13.23 13.62
Resistance 2 (R2) 13.23 12.79 13.25 13.53
Resistance 1 (R1) 12.71 12.52 12.39 12.76 13.43
Pivot Point 12.08 12.08 11.92 12.11 12.08
Support 1 (S1) 11.56 11.64 11.25 11.62 10.95
Support 2 (S2) 10.93 11.37 10.96 10.85
Support 3 (S3) 10.41 10.93 10.76
Support 4 (S4) 10.47